Supply Chain | July 18, 2025
Brenntag Specialties Pharma offering phosphate-based excipients by Budenheim
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
The company showcased three core programs developed through this platform
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
Subscribe To Our Newsletter & Stay Updated
